Comparison of Two Strategies for the Management of Atrial Fibrillation After Cardiac Surgery

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 380 participants.

Also called NCT04223739

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 380 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04223739
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
France (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04223739. Randomized; no masking; primary purpose treatment. Start 2019-12-13 (actual); primary completion 2021-06-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparison of Two Strategies for the Management of Atrial Fibrillation After Cardiac Surgery
Acronym
FAAC
Condition
Cardiac Surgery
Intervention (Drug)
Landiolol
Intervention (Drug)
Amiodarone
Lead sponsor
University Hospital, Caen (class: other)

Record details

Record id
cardio:ct-nct04223739
Content hash
adb9fb5cbb2bdbd8cf0aef642f631c278d3afcebe5da72f842a2b544fa7ed3a6